GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (FRA:CVG) » Definitions » Cyclically Adjusted Book per Share

CSPC Pharmaceutical Group (FRA:CVG) Cyclically Adjusted Book per Share : €0.18 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is CSPC Pharmaceutical Group Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

CSPC Pharmaceutical Group's adjusted book value per share for the three months ended in Dec. 2023 was €0.358. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.18 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-05-25), CSPC Pharmaceutical Group's current stock price is €0.7442. CSPC Pharmaceutical Group's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €0.18. CSPC Pharmaceutical Group's Cyclically Adjusted PB Ratio of today is 4.13.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of CSPC Pharmaceutical Group was 4.43. The lowest was 3.56. And the median was 3.83.


CSPC Pharmaceutical Group Cyclically Adjusted Book per Share Historical Data

The historical data trend for CSPC Pharmaceutical Group's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Cyclically Adjusted Book per Share Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.18

CSPC Pharmaceutical Group Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.18

Competitive Comparison of CSPC Pharmaceutical Group's Cyclically Adjusted Book per Share

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CSPC Pharmaceutical Group's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's Cyclically Adjusted PB Ratio falls into.



CSPC Pharmaceutical Group Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CSPC Pharmaceutical Group's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book= Book Value per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.358/114.7809*114.7809
=0.358

Current CPI (Dec. 2023) = 114.7809.

CSPC Pharmaceutical Group Quarterly Data

Book Value per Share CPI Adj_Book
200312 0.075 72.808 0.118
200412 0.073 74.488 0.112
200512 0.091 75.666 0.138
200612 0.046 77.793 0.068
200712 0.099 82.911 0.137
200812 0.145 83.956 0.198
200906 0.000 83.615 0.000
200912 0.155 85.386 0.208
201006 0.186 85.886 0.249
201012 0.022 89.289 0.028
201106 0.175 91.612 0.219
201112 0.031 92.885 0.038
201206 0.199 93.495 0.244
201212 0.124 95.237 0.149
201306 0.091 95.984 0.109
201312 0.065 97.624 0.076
201406 0.062 98.200 0.072
201412 0.075 99.000 0.087
201506 0.084 99.500 0.097
201512 0.092 100.600 0.105
201606 0.091 101.400 0.103
201612 0.107 102.600 0.120
201706 0.108 103.100 0.120
201712 0.137 104.500 0.150
201806 0.150 104.900 0.164
201812 0.161 106.500 0.174
201906 0.177 107.700 0.189
201912 0.198 111.200 0.204
202006 0.209 110.400 0.217
202012 0.234 111.500 0.241
202106 0.264 111.769 0.271
202112 0.302 113.108 0.306
202203 0.000 114.335 0.000
202206 0.332 114.558 0.333
202209 0.000 115.339 0.000
202212 0.343 115.116 0.342
202303 0.000 115.116 0.000
202306 0.345 114.558 0.346
202309 0.000 115.339 0.000
202312 0.358 114.781 0.358

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


CSPC Pharmaceutical Group  (FRA:CVG) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

CSPC Pharmaceutical Group's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.7442/0.18
=4.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of CSPC Pharmaceutical Group was 4.43. The lowest was 3.56. And the median was 3.83.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


CSPC Pharmaceutical Group Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


CSPC Pharmaceutical Group (FRA:CVG) Business Description

Traded in Other Exchanges
Address
No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.